mNexspike

FDA approves four new COVID vaccines for the 2026-27 season

by Michael Simpson
2026-08-31
BioNTech, COVID-19 vaccine, Moderna, Novavax, Pfizer

The US FDA has approved four COVID vaccines targeting the XFG variant for the 2026-2027 season, developed by Moderna, Pfizer and BioNTech, Novavax, and Sanofi. While the vaccines are available for high-risk individuals, the CDC’s lack of guidance leads to… Read More »FDA approves four new COVID vaccines for the 2026-27 season

FDA approves Fall 2025 COVID vaccines with restrictions

by Michael Simpson
2025-08-27
BioNTech, COVID-19 vaccine, Moderna, Novavax, Pfizer, Robert F Kennedy Jr

Rumors regarding HHS Secretary RFK Jr’s intent to eliminate COVID vaccines have surfaced, but the FDA approved new versions for Fall 2025. While vaccines are available for all individuals 65 and older, those under 64 must have high-risk conditions to… Read More »FDA approves Fall 2025 COVID vaccines with restrictions